Carruthers R Michael
CIK 0001644467
Chief Financial OfficerDirector
Filings
19
Latest Aug 14, 2025
Issuers covered
3
Showing
19 of 19
Page 1
Track record
9 of 9 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 22% | -11.8% | -14.2% | +13.1% | -23.2% |
| 90 days | 9 | 44% | -2.8% | -8.9% | +16.7% | -36.5% |
| 180 days | 9 | 67% | -18.8% | +13.0% | +21.9% | -125.9% |
| 365 days | 8 | 63% | -10.0% | +29.5% | +46.6% | -117.3% |
Issuers
Companies where Carruthers R Michael has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | 12 | Aug 14, 2025 |
| ELEV | Elevation Oncology, Inc. | 5 | Jul 24, 2025 |
| RPHM | Reneo Pharmaceuticals, Inc. | 2 | May 30, 2025 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|